Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term administration & dosage. Found 206 abstracts

no pagination
Haas NB. Can chemotherapy alter the course of prostate cancer?. Semin Urol Oncol. 2001 Aug;19(3):212-21.
Haas N, Roth B, Garay C, Yeslow G, Entmacher M, Weinstein A, Rogatko A, Babb J, Minnitti C, Flinker D, Gillon T, Hudes G. Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer. Urology. 2001 Jul;58(1):59-64.
Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, Heinonen OP, Taylor PR, Barrett MJ, Albanes D. Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. The Prostate. 2001 Jan;46(1):33-8.
Huang CH, Treat J. New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors. Oncology. 2001 Jan;61 Suppl 1:14-24.
Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study. Clin Cancer Res. 2001 Jan;7(1):68-73.
Langer CJ. The emerging world role of irinotecan in lung cancer. Oncology (Huntingt). 2001 Jul;15(7 Suppl 8):15-21.
Langer CJ. The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer. Lung Cancer. 2001 Nov;34(2):297-303.
Langer CJ, Ruffer J, Rhodes H, Paulus R, Murray K, Movsas B, Curran W. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001 Sep;51(1):113-9.
Levy MH. Advancement of opioid analgesia with controlled-release oxycodone. Eur J Pain. 2001 Jan;5 Suppl A:113-6.
Meropol NJ, Niedzwiecki D, Hollis D, Schilsky RL, Mayer RJ. Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. Cancer. 2001 Apr;91(7):1256-63.
Obarzanek E, Kimm SY, Barton BA, Van Horn LL, Kwiterovich PO, Simons-Morton DG, Hunsberger SA, Lasser NL, Robson AM, Franklin FA, Lauer RM, Stevens VJ, Friedman LA, Dorgan JF, Greenlick MR. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics. 2001 Feb;107(2):256-64.
Obasaju C, Hudes GR. Paclitaxel and docetaxel in prostate cancer. Hematol Oncol Clin North Am. 2001 Jun;15(3):525-45.
O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study. J Clin Oncol. 2001 May;19(9):2413-21.
Ozols RF. The current role of gemcitabine in ovarian cancer. Semin Oncol. 2001 Apr;28(2 Suppl 7):18-24.
Pandya KJ, Yeap BY, Weiner LM, Krook JE, Erban JK, Schinella RA, Davis TE. Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882). Am J Clin Oncol. 2001 Feb;24(1):43-6.
Ranganathan S, McCauley RA, Dexter DW, Hudes GR. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells. Br J Cancer. 2001 Sep;85(5):735-40.
Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. J Clin Oncol. 2001 Sep 15;19(18):3801-7.
Sasson AR, Watson JC, Sigurdson ER. Hepatic artery infusional chemotherapy for colorectal liver metastases. Cancer Treat Res. 2001 Jan;109:279-98.
Schilder RJ, Gallo JM, Millenson MM, Bookman MA, Weiner LM, Rogatko A, Rogers B, Padavic-Shallers K, Boente M, Rosenblum N, Adams AL, Ciccotto S, Ozols RF. Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy. J Clin Oncol. 2001 Feb 15;19(4):1183-94.
Selvakumaran M, Bao R, Crijns AP, Connolly DC, Weinstein JK, Hamilton TC. Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element. Cancer Res. 2001 Feb 15;61(4):1291-5.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term administration & dosage

administration & dosage Human drug therapy Antineoplastic Combined Chemotherapy Protocols Male therapeutic use Female Middle Age US Gov't Support-PHS Paclitaxel analogs & derivatives Non-US Gov't Support Aged Treatment Outcome pathology adverse effects Prostatic Neoplasms effects adverse Oral Administration Estramustine Drug Administration Schedule Antineoplastic Agents Leucovorin Fluorouracil Clinical Trials Non-Small-Cell Lung Carcinoma Lung Neoplasms Adult Survival Analysis pharmacology Adenocarcinoma 80 and over Aged drug effects Camptothecin mortality genetics Colorectal Neoplasms Phytogenic Antineoplastic Agents Neoplasm Drug Resistance Disease Progression Enzyme Inhibitors chemically induced metabolism Adjuvant Chemotherapy blood analogs & enzymology pharmacokinetics Drug Dose-Response Relationship Neoplasm Proteins Tubulin derivatives Intravenous Infusions Microtubules Ovarian Neoplasms Cholesterol Cisplatin Prognosis secondary Cultured Tumor Cells Comparative Study Follow-Up Studies Uracil therapy antagonists & inhibitors Neoplasm Staging radiotherapy Mitoxantrone Topotecan Carboplatin Vitamin E Multivariate Analysis Prolactin Antisense Oligodeoxyribonucleotides Hydrocortisone Oxidoreductases Body Height Biotransformation Delayed-Action Preparations Local Neoplasm Recurrence Carcinoma use Trans-Activation (Genetics) Proportional Hazards Models Hematopoietic Stem Cell Transplantation Liver Neoplasms Hospitalization Gastrointestinal Diseases dosage Pain Genetic Vectors Ferritin Proto-Oncogene Proteins c-bcl-2 Interferon Alfa-2a Palliative Care Reverse Transcriptase Polymerase Chain Reaction etiology Edema Intra-Arterial Infusions diet therapy Protein Isoforms therapeutic Feasibility Studies methods physiopathology Neoplastic Gene Expression Regulation Randomized Controlled Trials Japan Colchicine Nutritional Status Fat-Restricted Diet Antineoplastic Antimetabolites Triglycerides Adolescent Testosterone Drug Combinations Hypercholesterolemia United States Phosphonoacetic Acid Mortality Neutropenia Tegafur Oxycodone Body Mass Index Syndrome Transfection bcl-2 Genes diagnosis Vinblastine Quality of Life Cell Lineage Linear Models Radioimmunoassay ultrastructure Risk Factors Aspartic Acid Phase I Clinical Trials Drug Synergism Dietary Fats Epithelial Cells Anaphylaxis Disease-Free Survival Liver Diseases Signal Transduction Etoposide Retroelements Type I DNA Topoisomerases Deoxycytidine Endometrial Neoplasms
Last updated on Friday, January 03, 2020